Ipca Laboratories

Sector: Healthcare

Followers

0
0
9
9
.
9
9
0
0
5
5
,
1
1
-7.10 (-0.47%)

As on 16 Jan, 2026 | 15:55

Open Trading A/c
Day Range
1,481.70
1,517.60
LH
52 Week Range
1,168.20
1,595.00
LH
Volume
* i
Bid / Ask
107,415.00
0.00 / 0.00

Ipca Laboratories Announcements

IPCA Laboratories Limited has informed the Exchange regarding 'Sale of 100% equity shares of wholly owned step-down subsidiary and Updation of Registered Office Address

13 Jan, 2026 | 11:16am • Source: NSE

IPCA Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on January 13, 2026

13 Jan, 2026 | 11:04am • Source: NSE

Sale of 100% equity shares of wholly owned step-down subsidiary and updation of Registered Office Address

13 Jan, 2026 | 10:54am • Source: BSE

Updation in Registered Office Address

13 Jan, 2026 | 10:44am • Source: BSE

Outcome of Board Meeting

13 Jan, 2026 | 10:40am • Source: BSE

The Company has enclosed herewith RTA Certificate for the quarter ended 31.12.2025.

08 Jan, 2026 | 11:44am • Source: BSE

IPCA Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

22 Dec, 2025 | 10:41am • Source: NSE

Closure of Trading Window

22 Dec, 2025 | 10:18am • Source: BSE

Inspection of Company''s Active Pharmaceutical Ingredients (APIs) manufacturing facility situated at Tarapur (Palghar-Maharashtra) by US FDA

05 Dec, 2025 | 02:30pm • Source: BSE

Clarification sought on Volume Movement

17 Nov, 2025 | 02:09pm • Source: BSE

The Exchange has sought clarification from Ipca Laboratories Ltd on November 17, 2025, with reference to Movement in Volume.<BR><BR>The reply is awaited.

17 Nov, 2025 | 01:55pm • Source: BSE

Transcript of the Conference Call held on 13th November, 2025

17 Nov, 2025 | 01:04pm • Source: BSE

Copy of Newspaper Publication

14 Nov, 2025 | 03:10pm • Source: BSE

IPCA Laboratories Limited has informed the Exchange about the revised Schedule of meet

12 Nov, 2025 | 10:18am • Source: NSE

Conference Call for Q2FY26 Results

12 Nov, 2025 | 10:09am • Source: BSE

Conference Call to discuss Q2FY26 Results

06 Nov, 2025 | 12:46pm • Source: BSE

Slump Sale of Company''s API and Drug Intermediates Manufacturing unit situated at Ankleshwar

17 Oct, 2025 | 05:27pm • Source: BSE

Outcome of Board Meeting

17 Oct, 2025 | 05:24pm • Source: BSE

Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and...

17 Oct, 2025 | 03:45pm • Source: BSE

IPCA Laboratories Limited has informed the Exchange about incorporation of new subsidiary in Germany

16 Oct, 2025 | 11:13am • Source: NSE